Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · May 30, 2023

Glycemic Control With Once-Weekly Basal Insulin Fc Therapy vs Once-Daily Insulin Degludec Therapy in Insulin-Naive Patients With Type 2 Diabetes

Diabetes Care


Additional Info

Diabetes Care
Once-Weekly Basal Insulin Fc Demonstrated Similar Glycemic Control to Once-Daily Insulin Degludec in Insulin-Naive Patients With Type 2 Diabetes: A Phase 2 Randomized Control Trial
Diabetes Care 2023 May 01;46(5)1060-1067, JM Bue-Valleskey, CM Kazda, C Ma, J Chien, Q Zhang, E Chigutsa, W Landschulz, A Haupt, JP Frias

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading